CNS Pharmaceuticals Inc (CNSP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.22M
Last updated: Nov 17, 2026 at 10:56 AM ET
CNS Pharmaceuticals Inc (CNSP) Competitors
The companies most similar to CNS Pharmaceuticals are PharmaCyte Biotech (PMCB), Processa Pharmaceuticals (PCSA) and Traws Pharma (TRAW). By market cap, CNS Pharmaceuticals ranks 5th of the 13 companies on this page; Lantern Pharma (LTRN) is the largest at $6.47M.
Peer Comparison
CNSP's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| CNS Pharmaceuticals (CNSP) | $4.22M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Processa Pharmaceuticals Inc (PCSA) | $5.20M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Traws Pharma Inc (TRAW) | $3.86M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Neurosense Therapeutics Ltd (NRSN) | $3.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| NuCana PLC (NCNA) | $3.88M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Lantern Pharma Inc (LTRN) | $6.47M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Skye Bioscience, Inc. Common Stock (SKYE) | $4.83M | N/A | N/A | 0.0% | -3685.3% | 0.0% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | $4.02M | N/A | N/A | 0.0% | -247.2% | 0.0% | 0.00% |
| Clearmind Medicine Inc. Common Shares (CMND) | $2.30M | N/A | N/A | 0.0% | -56.8% | 0.0% | 0.00% |
| Can Fite Biopharma Ltd ADR (CANF) | $4.30M | N/A | 14.3x | 0.0% | -156.8% | 0.0% | 0.00% |
| Ernexa Therapeutics Inc. (ERNA) | $2.84M | N/A | N/A | 0.0% | N/A | -94.1% | 0.00% |
| Peer median | $3.87M | N/A | 7.9x | 0.0% | -202.0% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to CNS Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Processa Pharmaceuticals Inc (PCSA) | Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients... | PCSA competitors |
| Traws Pharma Inc (TRAW) | Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. | TRAW competitors |
| Curis Inc (CRIS) | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
| Neurosense Therapeutics Ltd (NRSN) | Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases... | |
| NuCana PLC (NCNA) | NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. | NCNA competitors |
| Lantern Pharma Inc (LTRN) | Lantern Pharma Inc., a clinical-stage biotechnology company, focuses on developing precision cancer therapies using artificial intelligence, genomics... | LTRN competitors |
| Skye Bioscience, Inc. Common Stock (SKYE) | Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops... | SKYE competitors |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN) | Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California. | LIMN competitors |
| Clearmind Medicine Inc. Common Shares (CMND) | Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems. | CMND competitors |
| Can Fite Biopharma Ltd ADR (CANF) | Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutics for the treatment of cancer... | |
| Ernexa Therapeutics Inc. (ERNA) | Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. | ERNA competitors |
Frequently Asked Questions About CNSP
Who are CNS Pharmaceuticals' main competitors?
The companies most similar to CNS Pharmaceuticals include PharmaCyte Biotech (PMCB), Processa Pharmaceuticals (PCSA), Traws Pharma (TRAW), Curis (CRIS) and Neurosense Therapeutics (NRSN), listed from the closest match.
Who is CNS Pharmaceuticals' biggest competitor?
Lantern Pharma (LTRN) is the largest of the similar companies at $6.47M; PharmaCyte Biotech (PMCB) is the closest match by business profile, size, sector and industry.
How does CNSP stock compare with its competitors?
CNSP's net margin is 0.0% against a peer median of 0.0%.
Which of CNS Pharmaceuticals' competitors pays a higher dividend?
CNS Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is CNS Pharmaceuticals bigger than its competitors?
No. CNS Pharmaceuticals is 5th by market cap among the 13 companies on this page; the largest is Lantern Pharma (LTRN) at $6.47M.
CNSP pages: Overview, Earnings, Forecast, Financials, Competitors